A Nature Cell Biology study shows that vitamin B2 metabolism helps cancer cells evade ferroptosis by stabilizing ferroptosis ...
Results from the phase 3 RECITE trial show that romiplostim significantly reduces chemotherapy-induced thrombocytopenia, ...
New findings from the phase III PRIMARY2 trial presented at EAU26 suggest that PSMA PET/CT imaging after inconclusive or reassuring MRI can safely reduce prostate biopsies by about 50 percent without ...
A nationwide U.S. study published in JAMA, analyzing data from 2.15 million women with breast cancer, found that choosing complementary and alternative medicine (CAM) instead of evidence-based therapy ...
Healthcare is entering a new digital era. Yet existing systems still rely on fragmented data and outdated software that struggle to support truly patient-centered care. Real progress now depends on ...
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...
The Phase III SUNMO trial could mark a breakthrough for transplant-ineligible patients with relapsed or refractory large B-cell lymphoma. In this ONCOLife interview, we spoke with Dr. Jason Westin, ...
Novartis strengthens expands its radioligand therapy arsenal with the acquisition of Mariana Oncology in a $1 billion deal. With this strategic move, Novartis has become a key player in the ...
Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. They not only infect and kill cancer cells, but also modulate the tumor micro-environment to enhance ...
The FDA has granted accelerated approval to sevabertinib (Hyrnuo), for previously treated HER2-mutated metastatic non-squamous non-small cell lung cancer, based on strong activity in the Phase I/II ...
BioNTech SE and Bristol Myers Squibb have partnered to co-develop and co-commercialize BNT327, a next-generation bispecific antibody targeting PD-L1 and VEGF-A in over 10 solid tumor indications. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results